HEALTH ECONOMICS
In a context of limited resources and increasing demands from decision-makers, health economic analysis is a critical lever for securing market access. MediTech Access supports healthcare innovators in generating robust economic evidence to inform pricing decisions, reimbursement negotiations, and strategic partnershipsโwhile maintaining cost-efficiency and managing risk.
HEALTH ECONOMIC MODELLING & STRATEGIC ACCESS
Delivering robust economic insights to demonstrate value
- Cost-Effectiveness & Cost-Utility Analyses : Rigorous modelling aligned with HAS requirements to support value demonstration and pricing decisions.
- Local Adaptation & Calibration : Tailoring global models to reflect country-specific clinical pathways, epidemiology, and cost data.
- Budget Impact Analysis (BIA) : Clear, payer-relevant projections of financial implications under real-world adoption scenarios.
REAL WORLD DATA & ANALYTICS
Actionable insights to strengthen your analyses
- Epidemiological and patient pathway through SNDS & PMSI databases
- Real-world validation of economic models and longitudinal tracking of healthcare consumption and outcomes
- Real-world input generation for model parameterization and
- Burden of disease analysis
DRG & NATIONAL COST DATA INSIGHTS
Informing pricing and hospital activity and cost structure
- DRG-based profiling of clinical activity and performance
- Strategic input for negotiations with payers
- Integration with real-world data for comprehensive medico-economic studies
COMPETITIVE LANDSCAPE & STRATEGIC POSITIONING
Supporting differentiation
- Access landscape mapping across therapeutic classes and indications
- Strategic segmentation and pricing strategies
- Design and implementation of positioning dashboards to inform strategic decision-making
WE DO NOT END THERE.
SEE HOW WE CAN SUPPORT YOU.
